title: Reply to Alexander et al (Subconjunctival anaesthesia for intravitreal injections).
authors.affiliation: Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK.
authors.forename: D A M
authors.initials: DA
authors.lastname: Lyall
authors.forename: A
authors.initials: A
authors.lastname: Tey
authors.forename: B
authors.initials: B
authors.lastname: Foot
authors.forename: S T D
authors.initials: ST
authors.lastname: Roxburgh
authors.forename: M
authors.initials: M
authors.lastname: Virdi
authors.forename: C
authors.initials: C
authors.lastname: Robertson
authors.forename: C J
authors.initials: CJ
authors.lastname: MacEwen
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D009877:Endophthalmitis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014821:Vitrectomy
chemical_list: D000900:Anti-Bacterial Agents; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A